Annual Current Liabilities
$19.24 M
-$178.21 M-90.25%
December 31, 2023
Summary
- As of February 7, 2025, RDHL annual total current liabilities is $19.24 million, with the most recent change of -$178.21 million (-90.25%) on December 31, 2023.
- During the last 3 years, RDHL annual current liabilities has fallen by -$53.99 million (-73.73%).
- RDHL annual current liabilities is now -90.25% below its all-time high of $197.45 million, reached on December 31, 2022.
Performance
RDHL Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$21.23 M
-$6.95 M-24.67%
June 1, 2024
Summary
- As of February 7, 2025, RDHL quarterly total current liabilities is $21.23 million, with the most recent change of -$6.95 million (-24.67%) on June 1, 2024.
- Over the past year, RDHL quarterly current liabilities has dropped by -$6.95 million (-24.67%).
- RDHL quarterly current liabilities is now -89.25% below its all-time high of $197.45 million, reached on December 31, 2022.
Performance
RDHL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RDHL Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -90.3% | -24.7% |
3 y3 years | -73.7% | -24.7% |
5 y5 years | +85.4% | -24.7% |
RDHL Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -90.3% | at low | -89.3% | at low |
5 y | 5-year | -90.3% | +81.3% | -89.3% | +100.0% |
alltime | all time | -90.3% | +3650.9% | -89.3% | +4039.0% |
RedHill Biopharma Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2024 | - | $21.23 M(-24.7%) |
Dec 2023 | $19.24 M(-90.3%) | - |
Jun 2023 | - | $28.19 M(-41.8%) |
Mar 2023 | - | $48.44 M(-75.5%) |
Dec 2022 | $197.45 M(+142.4%) | $197.45 M(+2.0%) |
Sep 2022 | - | $193.53 M(+16.3%) |
Jun 2022 | - | $166.41 M(+125.2%) |
Mar 2022 | - | $73.90 M(-9.3%) |
Dec 2021 | $81.47 M(+11.2%) | $81.47 M(-0.2%) |
Sep 2021 | - | $81.66 M(+3.1%) |
Jun 2021 | - | $79.17 M(+18.8%) |
Mar 2021 | - | $66.63 M(-9.0%) |
Dec 2020 | $73.23 M(+589.9%) | $73.23 M(+131.4%) |
Sep 2020 | - | $31.65 M(-11.8%) |
Jun 2020 | - | $35.87 M(+107.1%) |
Mar 2020 | - | $17.32 M(+63.2%) |
Dec 2019 | $10.62 M(+2.3%) | $10.62 M(-23.5%) |
Sep 2019 | - | $13.88 M(-1.2%) |
Jun 2019 | - | $14.05 M(+16.3%) |
Mar 2019 | - | $12.09 M(+16.4%) |
Dec 2018 | $10.38 M | $10.38 M(-5.6%) |
Sep 2018 | - | $11.00 M(+11.3%) |
Jun 2018 | - | $9.88 M(+1.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2018 | - | $9.71 M(-18.0%) |
Dec 2017 | $11.83 M(+120.9%) | $11.83 M(-1.7%) |
Sep 2017 | - | $12.03 M(+13.9%) |
Jun 2017 | - | $10.56 M(+82.5%) |
Mar 2017 | - | $5.79 M(+8.0%) |
Dec 2016 | $5.36 M(-2.9%) | $5.36 M(-26.5%) |
Sep 2016 | - | $7.29 M(+7.9%) |
Jun 2016 | - | $6.75 M(+21.0%) |
Mar 2016 | - | $5.58 M(+1.2%) |
Dec 2015 | $5.51 M(+220.6%) | $5.51 M(+33.0%) |
Sep 2015 | - | $4.14 M(+3.3%) |
Jun 2015 | - | $4.01 M(-26.6%) |
Mar 2015 | - | $5.46 M(+217.6%) |
Dec 2014 | $1.72 M(-28.8%) | $1.72 M(-33.4%) |
Sep 2014 | - | $2.58 M(-4.6%) |
Jun 2014 | - | $2.71 M(+121.1%) |
Mar 2014 | - | $1.23 M(-49.3%) |
Dec 2013 | $2.42 M(+124.0%) | $2.42 M(+25.5%) |
Sep 2013 | - | $1.92 M(+9.3%) |
Jun 2013 | - | $1.76 M(+32.3%) |
Mar 2013 | - | $1.33 M(+23.5%) |
Dec 2012 | $1.08 M(+110.1%) | $1.08 M(+32.1%) |
Sep 2012 | - | $816.00 K(+59.1%) |
Dec 2011 | $513.00 K | $513.00 K |
FAQ
- What is RedHill Biopharma annual total current liabilities?
- What is the all time high annual current liabilities for RedHill Biopharma?
- What is RedHill Biopharma annual current liabilities year-on-year change?
- What is RedHill Biopharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for RedHill Biopharma?
- What is RedHill Biopharma quarterly current liabilities year-on-year change?
What is RedHill Biopharma annual total current liabilities?
The current annual current liabilities of RDHL is $19.24 M
What is the all time high annual current liabilities for RedHill Biopharma?
RedHill Biopharma all-time high annual total current liabilities is $197.45 M
What is RedHill Biopharma annual current liabilities year-on-year change?
Over the past year, RDHL annual total current liabilities has changed by -$178.21 M (-90.25%)
What is RedHill Biopharma quarterly total current liabilities?
The current quarterly current liabilities of RDHL is $21.23 M
What is the all time high quarterly current liabilities for RedHill Biopharma?
RedHill Biopharma all-time high quarterly total current liabilities is $197.45 M
What is RedHill Biopharma quarterly current liabilities year-on-year change?
Over the past year, RDHL quarterly total current liabilities has changed by -$6.95 M (-24.67%)